The Department of Health Abu Dhabi in collaboration with G42 Healthcare and Abu Dhabi Health Services (SEHA) have announced the opening of a new screening and testing facility for volunteers who want to participate in clinical trials to combat COVID-19. Volunteers can apply through walk-in registrations. The facility is set to test the world’s first clinical Phase III trial of an inactivated vaccine to combat COVID-19.
ADNEC can process up to 1000 volunteers a day, including walk-in registrations. Those who have already registered online but have not yet had a follow-up call can also register on-site. Participants must have a negative COVID-19 test that was taken within the previous three (3) days. Participants must also be residents of Abu Dhabi.
The institute is run by a highly experienced and qualified team of nurses, administrators, healthcare professionals and volunteers. The facility will be open daily from 8 am to 8 pm, except on Friday.
The programme commenced on July 16th, and since then thousands of people from around the UAE have registered to become part of the trials.
Abu Dhabi-based G42 Healthcare is operating the trial process with the supervision of the Department of Health Abu Dhabi, and in coordination with Abu Dhabi Health Services (SEHA), who has specialised staff that runs the on-site operations.
There is a feasibility evaluation being conducted that hopes to set up similar sites in other parts of the UAE.
Phase I and Phase II trials conducted by Sinopharm in China were highly successful with, 100% of the volunteers generating antibodies after two doses in 28 days.
Phase III trials will last between six to eight months. The volunteers are required to be available for follow-ups during this time.
ALSO READ: UAE: COVID-19 detected by K9 police dogs